These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 31915281)

  • 21. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
    Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
    Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.
    Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS
    Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class II transactivator (CIITA) isoform expression and activity in melanoma.
    Baton F; Deruyffelaere C; Chapin M; Prod'homme T; Charron D; Al-Daccak R; Alcaide-Loridan C
    Melanoma Res; 2004 Dec; 14(6):453-61. PubMed ID: 15577315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
    Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
    Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
    Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
    J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
    Thompson JA; Dissanayake SK; Ksander BR; Knutson KL; Disis ML; Ostrand-Rosenberg S
    Cancer Res; 2006 Jan; 66(2):1147-54. PubMed ID: 16424052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.
    Pachot A; Monneret G; Brion A; Venet F; Bohé J; Bienvenu J; Mougin B; Lepape A
    Crit Care Med; 2005 Jan; 33(1):31-8; discussion 236-7. PubMed ID: 15644645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection.
    Jenkins C; Garcia W; Godwin MJ; Spencer JV; Stern JL; Abendroth A; Slobedman B
    J Virol; 2008 Apr; 82(7):3736-50. PubMed ID: 18216121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels.
    Kessler T; Reich M; Jahn G; Tolosa E; Beck A; Kalbacher H; Overkleeft H; Schempp S; Driessen C
    J Gen Virol; 2008 Oct; 89(Pt 10):2427-2436. PubMed ID: 18796710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion.
    Besold K; Frankenberg N; Pepperl-Klindworth S; Kuball J; Theobald M; Hahn G; Plachter B
    J Gen Virol; 2007 May; 88(Pt 5):1429-1439. PubMed ID: 17412970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
    Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of human sepsis on CCCTC-binding factor associated monocyte transcriptional response of Major Histocompatibility Complex II components.
    Siegler BH; Uhle F; Lichtenstern C; Arens C; Bartkuhn M; Weigand MA; Weiterer S
    PLoS One; 2018; 13(9):e0204168. PubMed ID: 30212590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal HLA-I genotype regulation by human cytomegalovirus US10 and resulting surface patterning.
    Gerke C; Bauersfeld L; Schirmeister I; Mireisz CN; Oberhardt V; Mery L; Wu D; Jürges CS; Spaapen RM; Mussolino C; Le-Trilling VTK; Trilling M; Dölken L; Paster W; Erhard F; Hofmann M; Schlosser A; Hengel H; Momburg F; Halenius A
    Elife; 2024 Jun; 13():. PubMed ID: 38900146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.
    Onno M; Pangault C; Le Friec G; Guilloux V; André P; Fauchet R
    J Immunol; 2000 Jun; 164(12):6426-34. PubMed ID: 10843698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of HLA expression in human cytomegalovirus immune evasion.
    Lin A; Xu H; Yan W
    Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CIITA enhances HIV-1 attachment to CD4+ T cells leading to enhanced infection and cell depletion.
    Porter KA; Kelley LN; Nekorchuk MD; Jones JH; Hahn AB; de Noronha CM; Harton JA; Duus KM
    J Immunol; 2010 Dec; 185(11):6480-8. PubMed ID: 21041720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.